Non-invasive diagnostic biomarkers for non-alcoholic steatohepatitis (NASH)

被引：0
|
作者：
Baranova, Ancha
Jarrar, Mohammed
Nugent, Clare
Afendy, Arian
Quigley, Caitlin
Stepanova, Maria
Elariny, Hazem
Goodman, Zachary
Chandhoke, Vikas
Younossi, Zobair M.
机构：
[1] Inova Hlth Syst, Translat Res Inst, Annandale, VA USA
[2] George Mason Univ, Dept Mol & Microbiol, Manassas, VA USA
[3] Inova Fairfax Hosp, Inova Hlth Syst, Liver Dis Ctr, Annandale, VA USA
[4] Armed Forces Inst Pathol, Washington, DC 20306 USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1116
引用
收藏
页码：733A / 733A
页数：1
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease (NAFLD). Non-alcoholic steatohepatitis - NASH
    Keller, KM
    MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (08) : 864 - 869
  • [32] A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease
    Eng, Katharine
    Lopez, Rocio
    Liccardo, Daniela
    Nobili, Valerio
    Alkhouri, Naim
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (11) : 1008 - 1013
  • [33] Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma
    Cuadrado, A
    Orive, A
    García-Suárez, C
    Domínguez, A
    Fernández-Escalante, JC
    Crespo, J
    Pons-Romero, F
    OBESITY SURGERY, 2005, 15 (03) : 442 - 446
  • [34] Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma
    Antonio Cuadrado
    Aitor Orive
    Covadonga García-Suárez
    Agustín Domínguez
    Jose Carlos Fernández-Escalante
    Javier Crespo
    Fernando Pons-Romero
    Obesity Surgery, 2005, 15 : 442 - 446
  • [35] Effect of phlebotomy on non-alcoholic steatohepatitis (NASH).
    Nitecki, J
    Jackson, FW
    Allen, ML
    Farr, VL
    Jackson, FW
    GASTROENTEROLOGY, 2000, 118 (04) : A1474 - A1474
  • [36] Progression of disease in non-alcoholic steatohepatitis (NASH)
    Kaplan, KJ
    Katz, DE
    Holtzmuller, KC
    Sjogren, MH
    Goodman, ZD
    LABORATORY INVESTIGATION, 1999, 79 (01) : 164A - 164A
  • [37] Laboratory predictors of non-alcoholic steatohepatitis (NASH)
    Bilici, A
    Unsal, B
    McGee, A
    Bolukoglu, H
    Ankoma-Sey, V
    Edwards, M
    HEPATOLOGY, 1999, 30 (04) : 438A - 438A
  • [38] The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Goh, George B. B.
    Issa, Danny
    Lopez, Rocio
    Dasarathy, Srinivasan
    Dasarathy, Jaividhya
    Sargent, Ruth
    Hawkins, Carol
    Pai, Rish K.
    Yerian, Lisa
    Khiyami, Amer
    Pagadala, Mangesh R.
    Sourianarayanane, Achuthan
    Alkhouri, Naim
    McCullough, Arthur J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) : 995 - 1000
  • [39] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
  • [40] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
12345